BREAKING NEWS: HHS @seckennedy just announced that the FDA is taking a step toward restoring science based access by removing 12 peptides from Category 2. FDA is moving them to an independent scientific A federal review is underway that could reclassify 14 peptides into FDA Category 1. This change that may influence how peptide therapies are accessed in the U.S. Here's what experts are 2025 FDA approvals FDA Category 2 Update: The 5 Peptides Still Facing Heavy Review As excitement builds around peptides potentially moving off the FDA Category 2 list, it's important to understand one key reality: Not